Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic postprostatectomy irradiation.

Emad Youssef1, Jeffrey D Forman, Samuel Tekyi-Mensah

  • 1Gershenson Radiation Oncology Center, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

Clinical Prostate Cancer
|March 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the Use of the Fast Health Care Interoperability Resources (FHIR) Standard to Support Data Activities Across the PCORnet® Infrastructure: Lessons Learned From the FHIR Pilots of the Coordinating Center for PCORnet®.

Medical care·2026
Same author

A Five-Year Review of Newborn Screening for Spinal Muscular Atrophy in the State of Utah: Lessons Learned.

International journal of neonatal screening·2024
Same author

Comparing Cyclic Fatigue Resistance and Free Recovery Transformation Temperature of NiTi Endodontic Single-File Systems Using a Novel Testing Setup.

Materials (Basel, Switzerland)·2024
Same author

ClinGen variant curation expert panel recommendations for classification of variants in GAMT, GATM and SLC6A8 for cerebral creatine deficiency syndromes.

Molecular genetics and metabolism·2024
Same author

Management of Teeth with Grade 3 Endo-Periodontal Lesions by Combined Endodontic and Regenerative Periodontal Therapy.

Journal of clinical medicine·2024
Same author

A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters.

Alcohol, clinical & experimental research·2023
Same journal

A phase II trial of 17-allylamino-17- demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.

Clinical prostate cancer·2005
Same journal

Orbital metastasis from prostate cancer: an atypical case of neuroendocrine dedifferentiation during progression from hormone-sensitive to refractory stage.

Clinical prostate cancer·2005
Same journal

Recent trends in surgical treatment of localized prostate cancer.

Clinical prostate cancer·2005
Same journal

Molecular effects of the isoflavonoid genistein in prostate cancer.

Clinical prostate cancer·2005
Same journal

Prostate-specific membrane antigen vaccines: naked DNA and protein approaches.

Clinical prostate cancer·2005
Same journal

Prior estrogen therapy as a predictor of response to subsequent estramustine-based chemotherapy in patients with androgen-independent prostate cancer.

Clinical prostate cancer·2005
See all related articles

External beam radiation for elevated postprostatectomy prostate-specific antigen (PSA) levels shows poor outcomes. A decreasing PSA during treatment significantly improves biochemical relapse-free survival, while higher pretreatment PSA levels predict failure.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Background:

  • Elevated prostate-specific antigen (PSA) after prostatectomy indicates residual cancer.
  • External beam radiation therapy (EBRT) is a treatment option for rising PSA levels.
  • Predicting outcomes for patients receiving salvage EBRT is crucial for treatment planning.

Purpose of the Study:

  • To evaluate the efficacy of external beam radiation for patients with elevated postprostatectomy PSA.
  • To identify predictors of biochemical relapse-free survival (bNED) after salvage EBRT.
  • To inform alternative treatment strategies for this patient group.

Main Methods:

  • Retrospective analysis of 108 patients treated with EBRT for elevated postprostatectomy PSA (1991-1998).
  • Median radiation dose of 68 Gy; PSA levels monitored during and after treatment.

Related Experiment Videos

  • Biochemical failure defined as a rising PSA > 0.2 ng/mL; bNED survival calculated using actuarial methods.

    • Main Results:

    • 54% of patients experienced biochemical failure; 5-year bNED survival was 39%.
    • A decreasing PSA trend during treatment was associated with significantly better 5-year bNED survival (43% vs. 10%).
    • Higher preradiation PSA levels and a rising PSA trend during treatment were significant predictors of failure.

    Conclusions:

    • Salvage external beam radiation for elevated postprostatectomy PSA yields poor outcomes.
    • Preradiation PSA level and PSA trend during treatment are key predictors of success.
    • Alternative strategies like early adjuvant irradiation or combined hormonal/radiation therapy should be explored.